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 INTRODUCTION
Maintenance of normal oxygenation, ventilation and
perfusion (the ABC of resuscitation) is essential in the
neurological patient to prevent secondary neurological
injury or exacerbation of the underlying condition. In
addition, correction of hypoxaemia, hypercapnia and
poor perfusion are the most important strategies for
reducing  intracranial  pressure  (ICP).  The  type  and
extent of supportive care required will depend on the
cause of respiratory and/or cardiovascular impairment
and the severity of disruption to normal oxygenation,
ventilation and perfusion. Techniques for maintaining
normal  respiratory  and  cardiovascular  function  and,
therefore, adequate oxygen delivery to the tissues are
outlined in this chapter. 
PROVIDING  AN ARTIFICIAL AIRWAY
The indications for providing an artificial airway are
listed below:
•L a r y n g e a l   p a r e s i s   o r   p a r a l y s i s ,   w h i c h   c a n   b e   c a u s e d
by cranial nerve deficits associated with disorders of
the brainstem or generalized neuromuscular
disease.
•L a r y n g e a l   s p a s m   ( e . g .   t e t a n u s ) .
•A n   i n a b i l i t y   t o   p r o t e c t   t h e   a i r w a y   a d e q u a t e l y
(e.g. severe depression/recumbency associated with
intracranial disease).
•M e c h a n i c a l   v e n t i l a t i o n .
Treatment methods for acquiring and maintaining
a patent airway
Oral endotracheal intubation 
Specific indications 
•E m e r g e n c y   m a n a g e m e n t   o f   u p p e r   a i r w a y
obstruction  (e.g. laryngeal spasm, laryngeal
paralysis). 
•P r o t e c t i o n   o f   a i r w a y   i n   a n   o b t u n d e d / u n c o n s c i o u s
animal. 
•A n i m a l s   t h a t   n e e d   m e c h a n i c a l   v e n t i l a t o r y   s u p p o r t .    
Precautions 
Oral  endotracheal  intubation  in  most  animals  will
require  sedation  or  anaesthesia.  Details  of  how  to
sedate/anaesthetize  a  neurological  patient  safely  are
descibed in Chapter 29.
Selection  of  an  appropriately  sized  endotracheal
tube (ETT) is essential (19). Resistance to breathing
is markedly  increased  as  the  diameter  of  the  ETT
decreases. If the diameter of the tube is halved, resistance
increases 16-fold. To minimize resistance to breathing,
the largest diameter tube that can be easily and safely
passed should be used. If the ETT is too long, resistance
to expiration will also increase (doubling the length will
double the resistance to flow) and the risk of excessive
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  19 Selection of an appropriate endotracheal tube for
each animal is required to ensure that resistance to
breathing is not excessive. When preparing for intubation,
select the most appropriate endotracheal tube size in
addition to tubes 0.5–1.0 mm above and below that size as
shown here.
9.0 mm
8.5 mm
8.0 mmequipment  dead  space  or  inadvertent  endobronchial
intubation increases (20). 
The  increased  work  of  breathing  associated  with
increased resistance can be overcome by mechanical
ventilation. The potential for this increased work to
reduce the adequacy of ventilation and cause hypercapnia
will be greatest in any animal expected to breathe sponta-
neously or when attempting to wean an animal off the
ventilator. An excessively long ETT will also increase the
apparatus dead space, leading to rebreathing of expired
carbon dioxide (CO2). This also increases the risk of
hypercapnia  and  increased  ICP  in  the  neurological
patient. 
As oral intubation bypasses the nasal cavity, which
normally humidifies inspired air, the airways are predis-
posed to desiccation. Humidification of gases is essential
to minimize drying of lower airways and should always
be used  in  patients  that  are  ventilated  for  anything
otherthan a short period of time.
Inflation of the ETT cuff is required to prevent aspi-
ration of saliva or gastric contents. The cuff should be
inflated just enough to create a seal. If excessive or pro-
longed inflation pressure is created, the risk of pressure
necrosis of the tracheal mucosa increases. The pressure
of the small arterioles in the tracheal mucosa is very low,
so  the  pressure  within  the  cuff  should  not  exceed
25 mmHg. Careful inflation of the cuff is required to
minimize  damage  to  the  mucosa.  During  prolonged
intubation, occasional repositioning of the endotracheal
tube  may  help  reduce  mucosal  ischaemia;  however, 
repositioning the ETT increases the risk of aspiration of
secretions that have accumulated above the cuff. If the
tube is repositioned, the pharynx and oesophagus should
be suctioned prior to cuff deflation to reduce the risk of
secretions entering the airway. 
Tracheostomy 
Specific indications
•C h r o n i c   m a n a g e m e n t   o f   a i r w a y   d y s f u n c t i o n   i n
conscious patients (e.g. animals with tetanus,
laryngeal paresis).  
•T o   r e d u c e   t h e   a m o u n t   o f   s e d a t i o n / a n a e s t h e s i a
required to immobilize animals requiring
mechanical ventilation.  
•S e v e r e   l a r y n g e a l   t r a u m a .
Precautions
The tracheostomy tube must be secured adequately in
place  to  prevent  accidental  removal  and  loss  of  the
airway. It is essential that the tube can still be removed
rapidly should obstruction occur. Tying the tube in place
is preferred over suturing (21). 
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  20 Endotracheal tubes and other apparatus (such as
the capnograph sampling connector; arrow) extending
beyond the level of the animal’s incisors may increase
apparatus dead space, resistance to expiration and the
work of breathing. Always pre-measure the endotracheal
tube before placement.
  21 A tracheostomy tube is used to provide a patent
airway in animals with severe compromise of the upper
respiratory tract. The tube should be tied in place (arrow)
to allow rapid removal should obstruction of the tube
occur.The  accumulation  of  secretions  may  occlude  the
tube. When mechanical ventilation is not required and
the risk of aspiration is considered minimal, it is rec-
ommended that an uncuffed tube is used (22). It is also
recommended that the diameter of the tube is one half
the diameter of the trachea, so the animal can breathe
around  the  tube  for  short  periods  should  the  tube
become occluded.
Care of the tracheostomy site is labour intensive.
Animals need constant monitoring, as occlusion of the
tube can result in death within minutes. Regular suction-
ing is required to prevent accumulation of secretions.
The tube should be replaced 1–2 times a day.  
Intratracheal catheter 
If the upper airway is completely obstructed, an intratra-
cheal  catheter  or  needle  (large  dog:  16  g;  small  to
medium dog: 18 g) can be placed (23). Oxygen can be
insufflated via these catheters/needles for <5 minutes.
Specific indications
• Obstructed airway and impending respiratory
arrest.
•S h o r t - t e r m   o x y g e n a t i o n   w h i l e   o r a l   i n t u b a t i o n   o r
tracheostomy is performed. 
Precautions 
This method of oxygenation is for short-term use only
(<5 minutes) and must be used with conservative oxygen
flow rates. When the airway is completely obstructed,
oxygen insufflated into the lung via a narrow needle or
catheter cannot be expired, therefore there is a risk of
rupturing the lung, resulting in a pneumothorax. To
determine suitable flow rates, the volume of the animal’s
lungs must be considered. For example: a 20 kg dog
would have an approximate tidal volume of 200 ml (based
on 10 ml/kg).  Therefore,  an  oxygen  flow  of  1  litre
minute-1 would fill the tidal volume of the lungs in 12
seconds, while an oxygen flow rate of 200 ml/minute
would take 1 minute. 
This method does not allow for mechanical venti-
lation of the animal, and hypercapnia will occur. Intu-
bation should be performed promptly and mechanical
ventilation  instigated  as  soon  as  a  patent  airway  is
available. 
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  22 A cuffed tracheostomy tube (a) is required when
mechanical ventilation is being performed. However,
when the animal is conscious and spontaneously
breathing, an uncuffed tracheostomy tube (b) is preferred.
  23 An intratracheal catheter, as shown here, can be
used to provide short-term (<5 minutes) oxygen supple-
mentation in animals that are completely obstructed. 
a
bBREATHING
Adequate oxygenation (arterial oxygen partial pressure
[PaO2]  80 mmHg [10.7 kPa]; saturation of haemo-
globin with oxygen [SpO2]  95%) and ventilation (arte-
rial  carbon  dioxide  partial  pressure  [PaCO2]  35–40
mmHg [4.7–5.3 kPa]; end-tidal carbon dioxide partial
pressure  [P’ETCO2]  30–35  mmHg  [4–4.7  kPa])  are
required  to  maintain  cerebral  oxygen  delivery  and
prevent increases in ICP. 
Oxygen supplementation
Indications 
Oxygen supplementation is indicated if there is a critical
decrease in oxygen delivery to the brain. Oxygen delivery
(DO2 ) is a product of cardiac output (CO) and oxygen
carrying  capacity  (CaO2)  measured  as  the  oxygen
content of arterial blood:
DO2= CO  CaO2
The oxygen content of arterial blood is a combination of
oxygen bound to haemoglobin (haemoglobin   SpO2  
1.34) and that dissolved in the plasma (0.003  PaO2). As
the majority of oxygen is carried in the blood bound to
haemoglobin, decreases in oxyhaemoglobin saturation
and haemoglobin concentration have the greatest influ-
ence on oxygen delivery to tissues, including the brain.
Decreases in oxygen saturation of haemoglobin may
occur  due  to  decreased  inspired  oxygen  percentage,
decreased ventilation or decreased transfer of oxygen
across the alveoli, or ventilation/perfusion mismatch or
right-to-left  shunting  of  pulmonary  blood  flow.  A
decrease in haemoglobin concentration (anaemia) will
occur due to blood loss or red cell destruction. 
Hypoxaemia 
Definition 
Although  only  a  small  amount  of  oxygen  is  carried
dissolved  in  blood,  assessment  of  oxygenation  is
frequently performed by measurement of PaO2. Severe
hypoxaemia is defined as a PaO2 of <60 mmHg (8 kPa).
This is equivalent to an SpO2of 90% (24). SpO2 is meas-
ured using pulse oximetry (see below). For animals with
intracranial disease, it is recommended that the PaO2 is
maintained at >80 mmHg (10.7 kPa) to prevent increas-
es in ICP.
Common causes of hypoxaemia in animals with
neurological disease 
• Aspiration pneumonia. Animals with CN deficits
associated with brainstem or neuromuscular
disease are predisposed to regurgitation and
aspiration due to impairment of upper respiratory
tract (URT) function. Recumbency and
severe depression also predispose the animal to
aspiration. 
•A t e l e c t a s i s   ( 25). Recumbency, immobility and a
high inspired oxygen concentration all predispose
to alveolar collapse. This creates a mismatch in
ventilation and perfusion and results in shunting of
blood through the lungs. The shunt prevents
oxygenation of the blood as it bypasses ventilated
alveoli.
•A c u t e   l u n g   i n j u r y   ( A L I ) .   L u n g   i n j u r y   s e c o n d a r y   t o
systemic inflammation, prolonged exposure to high
inspired oxygen concentrations and trauma due to
high ventilation pressures all contribute to the
incidence and severity of ALI. These processes
cause the release of inflammatory mediators within
the lung, which stimulate a vicious cycle of patho-
logical changes within the alveoli and surrounding
lung tissues. The net result is interference with
pulmonary gas exchange. ALI is tentatively
diagnosed when the ratio of arterial oxygen tension
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  24 Oxygen–haemoglobin dissociation curve.
Arterial (90%)
Mixed venous (75%)
2 4 6 8 10 12
Oxygen tension (kPa)
Oxygen tension (mmHg)
20 40 60 80 100
O
x
y
g
e
n
 
s
a
t
u
r
a
t
i
o
n
(
%
)
100
80
60
40
20
0
5.3 13.3to fractional inspired oxygen concentration
(PaO2:FiO2) is <300. Supportive care of ALI is
based on supplemental oxygenation via mask, nasal
catheters or oxygen cage. 
•A c u t e   r e s p i r a t o r y   d i s t r e s s   s y n d r o m e   ( A R D S ) .
ARDS occurs as the pathological changes in ALI
progress and cause greater interference with gas
exchange. ARDS is defined as a PaO2:FiO2 ratio of
<200. These patients require ventilatory support.
•P u l m o n a r y   c o n t u s i o n s   o r   p n e u m o t h o r a x   ( 26) in
animals with concurrent chest trauma.
•N e u r o g e n i c   o r   n o n - c a r d i o g e n i c   p u l m o n a r y   o e d e m a
occurs in response to increased sympathetic nervous
system stimulation and blood pressure (BP)
secondary to brainstem ischaemia or compression.
URT obstruction may also cause pulmonary
oedema if the negative pressures generated during
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  25 Recumbency and immobility are very common
causes of atelectasis and hypoxaemia in the neurological
patient.
  26 Pneumothorax secondary to chest trauma, as shown
in this lateral radiograph, can contribute to hypoxaemia in
animals with concurrent head trauma. (Photo courtesy
Shannon Holmes)
inspiration damage the alveolar membrane, causing
fluid to flood the alveoli.
•H y p o v e n t i l a t i o n .   I n   a n   a n i m a l   b r e a t h i n g   r o o m   a i r ,
hypoventilation causes increased alveolar CO2,
which dilutes alveolar oxygen and results in less
oxygen being available to diffuse into the arterial
blood. Restoring normal CO2 values by the use of
ventilation should also correct the hypoxaemia. If
the hypoxaemia is not corrected with ventilation
and the return of CO2 to normal, then other causes
of hypoxaemia need to be investigated. 
Management
Hypoxaemia is managed by treating the underlying cause
when  possible  and  providing  supplemental  oxygen
(see below) until the cause of the hypoxaemia has been
corrected.Anaemia 
The clinical significance of anaemia varies according to
whether the anaemia is acute or chronic:
•A c u t e   a n a e m i a   ( e . g .   h a e m o r r h a g e ) :   c l i n i c a l   s i g n s
will usually occur if the PCV (packed cell volume) is
<0.30 l/l (30%) in dogs and <0.25 l/l (25%) in cats.
•C h r o n i c   a n a e m i a   ( e . g .   h a e m o l y t i c   a n a e m i a ) :   c l i n i c a l
signs will generally be apparent when the PCV is
<0.20 l/l (20%) in dogs and <0.15 l/l (15%) in cats.
Causes of anaemia in neurological disease 
The most common cause is haemorrhage secondary to
trauma or surgical blood loss.
Management 
The definitive treatment for reduced tissue oxygenation
due to anaemia is whole blood or red blood cell (RBC)
transfusion. For further information on blood transfu-
sion see Chapter 31.
If there is a delay in administering blood or RBCs,
oxygen supplementation can be useful. While oxygen
supplementation  in  these  cases  may  only  provide
extremely  small  amounts  of  dissolved  oxygen  in  the
blood, this can be life saving in the short term. 
Treatment methods for supplementing oxygen
Increasing the FiO2
The aim of techniques that increase the inspired per-
centage of oxygen is to use the lowest FiO2 that will
maintain the PaO2at between 80 and 100 mmHg (10.7–
13.3 kPa). As haemoglobin is fully saturated when the
PaO2 is approximately 100 mmHg (13.3 kPa), further
increases in arterial oxygen tension produce very little
increase in the amount of oxygen carried by the blood. In
addition, there is an increased risk of lung damage as
exposure to higher than normal levels of alveolar oxygen
triggers  pathological  changes  within  the  pulmonary
tissues (oxygen toxicity). The higher the alveolar oxygen
tension and the longer the duration of treatment, the
greater the risk of irreversible alveolar damage. 
Increased  inspired  oxygen  can  be  delivered  by  a
number of methods, including oxygen cage, head collar,
mask or nasal catheter.
• Oxygen cage. Cages are useful for initial stabiliza-
tion of small dogs and cats in respiratory distress
while minimizing the stress of handling (27). The
advantage of using an oxygen cage is that an FiO2
of >50% can be achieved when the cage remains
closed. The disadvantages include limited access to
the patient if continuous oxygen support is
required. In addition, patients are also at risk of
hyperthermia and should be monitored carefully. 
• Head collar. Head collars can be used for larger
animals where size prevents the use of oxygen
cages. The use of head collars covered with plastic
film can provide a personalized oxygen cage.
Oxygen is delivered via tubing attached on the
inside of the head collar (28). Head collars have the
advantage of providing a high FiO2 while still
allowing access to the rest of the animal. The
disadvantages include: 
• The risk of jugular occlusion and increased ICP
if the collar is too tight. 
• Hypercapnia can occur if the collar is tight, the
oxygen flow is too low or the supply tubing
becomes disconnected, allowing CO2 to build up
within the enclosed head collar. Hypoxaemia will
also develop if the oxygen tubing detaches. Flow
rates equivalent to those used in non-
rebreathing anaesthetic systems (200–300
ml/kg/minute) are probably adequate. 
• Hyperthermia can also occur with this technique
as the animal is rebreathing expired warm and
humidified air. 
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  27 An oxygen cage can be used to provide oxygen
supplementation in small- to medium-sized animals.RESPIRATORY AND CARDIOVASCULAR SUPPORT 41
  29 Face masks can be used to provide oxygen during
initial stabilization or prior to induction of anaesthesia.
  30 ‘Flow-by’ oxygen therapy can be used to provide
short-term oxygen supplementation to animals that will
not tolerate a face mask.
  31 Nasal catheters can be used to provide continuous
oxygen supplementation and also allow continuous access.
They should be avoided in animals with increased
intracranial pressure, coagulopathy and nasal fractures.
  28 A head collar covered in plastic film can be used to
provide oxygen supplementation to larger animals when
other methods are not feasible. Care should be taken to
avoid jugular vein compression and overheating. 
• Face mask. Face masks are generally used for initial
stabilization only, particularly in animals not
amenable to oxygen cages due to their size (29). The
advantage of using face masks for oxygen
supplementation is that they are easily accessible and
allow for prompt administration of oxygen in an
emergency setting. One of the disadvantages is that
animals in respiratory distress may not tolerate a
mask held over their face. In these cases ‘flow-by’
oxygenation can be used (30). A tight-fitting mask
can also exacerbate hyperthermia, as rebreathing of
expired humidified gases occurs. An open mask or
flow-by technique provides limited increase in FiO2.
• Nasal catheter. An intranasal catheter is inserted
into the ventral nasal meatus, directing the catheter
ventromedially (31). The tip can be positioned just
inside the nostril or in the nasopharynx. To position the catheter tip in the nasopharynx, the
catheter should be pre-measured to the level of the
medial canthus to ensure correct positioning. If the
tip is inserted too far, it risks being introduced into
the oesophagus, causing aerophagia and gastric
dilation. Most animals will tolerate an oxygen flow
of 100 ml/kg/minute/nostril. Higher flows may
cause increased irritation, sneezing or removal of
the catheter by the patient. If flows >100 ml/kg/
minute are required to achieve adequate oxygena-
tion, a catheter can be placed in each nostril,
allowing a total oxygen flow of up to 200 ml/kg/
minute to be delivered comfortably. Nasal catheters
have the advantage of allowing long-term supple-
mentation of oxygen in animals with respiratory
disease and continuous access to the patient.
Furthermore, there is no risk of hyperthermia or
hypercapnia. The disadvantages include sneezing
associated with placement of nasal catheters, which
can be detrimental if there is: (1) increased ICP, as
sneezing will cause further increases, which may
result in fatal herniation of the brainstem, or (2)
coagulopathy, as sneezing may cause bleeding from
the nostril or haemorrhage into the eye or brain.
This procedure should also be avoided in the head-
trauma patient, when fractures within the nasal
cavity can lead to misplacement of the catheter
within neural tissue. Finally, there is a limited
increase in FiO2 of 0.3–0.4 (30–40% inspired
oxygen concentration) observed with this method.
Endotracheal intubation
Endotracheal intubation and connection to a breathing
system  may  be  necessary  when  other  methods  of
increasing FiO2fail to achieve adequate arterial oxygen
tension or if the animal becomes increasingly depressed
(32). Intubation must be performed before the animal
becomes unconscious. This will require careful admin-
istration of intravenous anaesthetic agents. If intubation
is  delayed  until  the  animal  becomes  unconscious
because of the pathological process, cardiopulmonary
arrest is highly likely. 
Endotracheal intubation has the advantage of allow-
ing connection to a breathing system and the delivery of
100% oxygen. The clinician can therefore be more con-
fident  of  the  delivered  FiO2.  Disadvantages  include:
(1) maintenance of oral endotracheal tubes generally
requires some degree of sedation or anaesthesia and
(2) the depressant effects of sedative and anaesthetic
agents will also necessitate some form of positive pres-
sure ventilation, particularly in animals with intracranial
disease where maintenance of normal PaCO2is essential.  
Assisted ventilation is indicated when increasing FiO2
fails to correct hypoxaemia (33). Details of ventilation
techniques are described in the next section. 
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  32 Endotracheal intubation and delivery of high
inspired oxygen concentration may be needed in animals
that do not improve with other methods of oxygen
supplementation.
  33 Mechanical ventilation is commonly used to
‘breathe’ for patients that have inadequate spontaneous
ventilation or are unresponsive to other methods of
oxygen supplementation.VENTILATION
The  aim  of  mechanical  ventilation  is  to  recruit  and
stabilize  alveoli  and  deliver  oxygen  to  and  remove
carbon dioxide from them without causing lung injury.
Careful  monitoring  of  ventilation  to  ensure  normo-
capnia and satisfactory oxygenation is essential to guide
management strategies. Furthermore, the haemodyn-
amic consequences of mechanical ventilation should be
continuously monitored. During spontaneous ventila-
tion, a negative pressure is created within the thoracic
cavity to draw air into the lungs. During mechanical
ventilation, a positive pressure is generated to push gas
into the lungs. This positive pressure compresses blood
vessels within the chest, especially in the low-pressure
venous circulation and right side of the heart. The net
effect is a decrease in cardiac output. Ideally, cardiac
output should be monitored in ventilated animals, but
arterial BP measurement is a common surrogate measure
in a clinical setting.
Mechanical ventilation is indicated in animals with
respiratory failure. Respiratory failure can be divided
into two types:
• Hypercapnic ventilatory failure (inadequate
alveolar ventilation = hypoventilation): generally
considered to be present when the PaCO2 is
>50 mmHg (6.7 kPa). Ventilatory failure should
also be considered in animals with normal PaCO2
if there is: (1) clinical evidence of increased
respiratory work and impending fatigue (high
respiratory rate; change in respiratory pattern;
increased inspiratory effort; erratic changes in 
tidal volume and/or respiratory frequency), or
(2) inadequate respiratory compensation for
metabolic acidosis. In animals with intracranial
disease, any increase in CO2 may have detrimental
effects on ICP.  Mechanical ventilation is required
in any animal with intracranial disease if the
PaCO2 is >40 mmHg  (5.3 kPa). The causes of
ventilatory failure in animals with neurological
disease include:
• Neuromuscular weakness: tetrodotoxin, snake
envenomation, tick paralysis, botulism,
polyradiculoneuritis, myasthenia gravis (MG).
• Cervical spinal cord injury.
• Intracranial disease with involvement of
respiratory centres (i.e. caudal fossa pathology).
• Drug-induced CNS depression: anaesthesia,
opioid overdose.
• Hypoxaemic respiratory failure (inadequate
oxygen exchange): generally defined as arterial
oxygen tension <60 mmHg (8 kPa) when the FiO2
is >0.5.
Treatment methods for providing ventilation
The most common type of ventilation used routinely in
animals  is  intermittent  positive  pressure  ventilation
(IPPV). The factor determining the termination of inspi-
ration and the onset of expiration is most often volume,
pressure  or  time.  Positive  end-expiratory  pressure
(PEEP) and continuous positive airway pressure (CPAP)
are also used, particularly in animals with pulmonary
pathology. Table 6  gives a summary of the modes of ven-
tilation that can be used in neurological patients. 
RESPIRATORY AND CARDIOVASCULAR SUPPORT 43
Table 6 Modes of mechanical ventilation
MODE MECHANISM USES/ADVANTAGES DISADVANTAGES/CAUTIONS
Volume-cycled IPPV Inspiration terminated when  Preferred use in normal lungs Increases risk of lung injury 
pre-set volume delivered. in animals with altered lung 
Delivers desired VT regardless   compliance
of lung compliance
Pressure-cycled IPPV Inspiration is terminated when a  Preferred method for animals  Poor airway, lung or chest wall
pre-set pressure is delivered. VT with altered lung compliance  compliance will require high 
will therefore be determined by  or very small patients inflation pressures to achieve an
lung and chest wall compliance  adequate minute volume
(Continued)A wide range of other ventilation strategies are used
to promote ventilation and oxygenation, minimize lung
injury and prevent haemodynamic compromise. Tech-
niques  including  high-frequency  ventilation,  inverse
ratio ventilation, biphasic airway pressure and extra-
corporeal membrane oxygenation have been used to
reduce airway pressures in human patients with severe
pulmonary  disease.  These  techniques  are  limited  to
specialist centres with specialist equipment, a thorough
understanding of which is essential before embarking on
either  short-  or  long-term  management.  A  detailed
description of the equipment and techniques is beyond
the scope of this book. For more information, the reader
is referred to the Further reading list, p. 623. 
Adverse effects of ventilation 
Mechanical  ventilation  may  have  numerous  adverse
effects  on  a  variety  of  body  systems,  including  the
cardiovascular,  respiratory,  neurological,  renal  and
gastrointestinal systems. A summary of these effects and
how to minimize them is given in Table 7. Before ventila-
tion of any animal is undertaken it is essential to under-
stand the potential adverse effects and how to avoid
them.
Guidelines for use of mechanical ventilation
The aim of ventilation is to optimize oxygenation and
ventilation, while minimizing adverse effects on cardio-
vascular, pulmonary and neurological functions.  
Different ventilatory strategies are used to manage
different types of respiratory failure. The ventilation
strategy may need to be further altered if the animal has
concurrent intracranial disease. Guidelines for use of
ventilation in these situations are described below (see
also Table 8, page 46).
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Table 6 Modes of mechanical ventilation (continued)
MODE MECHANISM USES/ADVANTAGES DISADVANTAGES/CAUTIONS
Time-cycled IPPV Inspiration is terminated when  Infrequently used in current  PIP is determined by lung and 
a set inspiration time has passed. clinical practice chest wall compliance. Decreases 
VT is determined by lung and  in compliance will cause 
chest wall compliance increases in PIP and increase 
risk of injury
OTHER DEFINITIONS
PEEP Maintains positive pressure  Minimizes atelectasis and High PEEP may compromise 
at the end of expiration during  associated ventilation/perfusion  venous return and cardiac 
controlled ventilation, preventing  mismatch in normal lungs. output. Decreased venous
complete alveolar collapse at   Minimizes volutrauma in lung return can lead to increased 
the part of the respiratory cycle  pathology cerebral blood volume and 
when airway pressure is usually increased ICP
0 cmH2O
CPAP Technique used in spontaneously  Can help stabilize open alveoli  Animals may not tolerate nasal
breathing animals to prevent  and prevent alveolar collapse. catheters or prongs. Higher 
alveolar collapse at the end of May improve oxygenation in  than normal pressure at the 
expiration and increase   spontaneously breathing  end of expiration may 
functional residual capacity animals and negate need  compromise venous return and 
for IPPV cardiac output
VT = tidal volume; PEEP = positive end-expiratory pressure; CPAP = continuous positive airway pressure; ICP = intracranial pressure;
PIP = peak inspiratory pressure; IPPV = intermittent positive pressure ventilation.RESPIRATORY AND CARDIOVASCULAR SUPPORT 45
Table 7 Adverse effects of mechanical ventilation
SYSTEM  EFFECT  METHODS OF MINIMIZING ADVERSE EFFECTS
Cardiovascular 
Pulmonary 
Renal function
Gastrointestinal system
Central nervous system
VT = tidal volume; RR = respiratory rate; PIP = peak inspiratory pressure; PEEP = positive end-expiratory pressure;
CPAP = continuous positive airway pressure; ICP = intracranial pressure; CVP = central venous pressure; CO = cardiac output;
GFR = glomerular filtration rate; SIRS = systemic inflammatory response syndrome; MOF = multiple organ failure;
ADH = antidiuretic hormone;ANP = atrial natriuretic peptide; IPPV = intermittent positive pressure ventilation.
Positive airway pressure during IPPV interferes
with venous return and CO during inspiration.
CPAP and PEEP interfere with venous return 
and CO during expiration. PEEP in combination
with IPPV interferes with venous return
throughout the respiratory cycle. Decreased 
CO leads to decreased oxygen delivery to the
tissues and may offset improvement in oxygen
content
Barotrauma: excessive airway pressure causes
physical disruption of lung tissue and extra-
alveolar air (e.g. pneumothorax).Volutrauma:
overdistension of alveoli causes increased perme-
ability, oedema and inflammation. Repetitive
stretching and recoil of alveoli induces inflamma-
tory and structural changes, leading to increased
permeability of alveoli and oedema formation.
Inflammation associated with ventilator-induced
lung injury may be an important inciting factor for
development of SIRS and MOF
Decreased urine output due to release of ADH and
decreasing ANP production causing fluid retention.
Decreased GFR and intrarenal blood flow redistrib-
ution may interfere with the renal elimination of
drugs
Increased incidence of gastric ulceration and liver
dysfunction. Decreased portal blood flow may also
reduce the elimination of drugs that undergo
hepatic metabolism
Interference with venous return can lead to
increased cerebral venous blood volume and ICP
•T o   m i n i m i z e   t h e   d e t r i m e n t a l   e f f e c t s   o n   c a r d i o -
vascular performance it is important to ensure
adequate blood volume and minimize PIP, the
amount of time spent in inspiration (inspiratory
time) and PEEP.
•M o n i t o r   b l o o d   p r e s s u r e   a n d   C V P   d u r i n g
ventilation.
•M o n i t o r   I C P   i n   a n i m a l s   w i t h   i n t r a c r a n i a l
disease.
•U s e   t h e   m i n i m u m   V T and PIP necessary to
achieve adequate oxygenation and ventilation.
•L u n g   d i s e a s e : l o w e r   V T,h i g h e r   R R   a n d   P E E P .
Slight hypoventilation and permissive hyper-
capnia (PaCO2 45–60 mmHg).
Note: Permissive hypercapnia must be avoided
in patients with intracranial disease.
•U s e   t h e   m i n i m u m   V T and PIP necessary to
achieve adequate oxygenation and ventilation.
•U s e   t h e   m i n i m u m   V T and PIP necessary to
achieve adequate oxygenation and ventilation.
•U s e   t h e   m i n i m u m   V T and PIP necessary to
achieve adequate oxygenation and ventilation.
•N e u r o m u s c u l a r     r e l a x a t i o n   i n   a n a e s t h e t i z e d
animals can help reduce the PIP required to
ventilate to normocapnia.
•U s e   P E E P   v e r y   c a r e f u l l y   i n   a n i m a l s   w i t h   i n t r a -
cranial disease.
•M o n i t o r   C V P   a n d   I C P   i n   a n i m a l s   w i t h   i n t r a -
cranial disease.ADMISSION AND NEURODIAGNOSTIC TESTS 46
Table 8 Guidelines for mechanical ventilation
NORMAL LUNGS ABNORMAL LUNGS INTRACRANIAL DISEASE
Preferred Pressure or volume cycled Pressure cycled Pressure cycled
ventilator type
Settings
VT 10–20 ml/kg <6 ml/kg 
RR Comparable to resting respiratory  Adequate to maintain appropriate 
rate F’EtCO2 
I:E ratio 1:3 1:3 
PIP 10–20 cmH2O will adequately  Higher PIP required due to reduced 
ventilate most animals with compliance (see Further reading)
normal lungs; cats will sometimes
require <10 cmH2O due to higher
chest compliance
PEEP 0–5 cmH2OS t a r t   a t   3   c m H 2O and increase 
up to 10 cmH2O as required 
to achieve adequate oxygenation
without decreasing oxygen delivery
VT = tidal volume; RR = respiratory rate; I:E ratio = inspiratory:expiratory time ratio; PIP = peak inspiratory pressure;
PEEP = positive end-expiratory pressure; ICP = intracranial pressure; F’ECO2.=   F r a c t i o n a l   c o n c e n t r a t i o n   o f   c a r b o n   d i o x i d e   i n   m i x e d   e x p i r e d   a i r
Mechanical ventilation in cases of ventilatory failure
In animals with ventilatory failure, peak inspiratory
pressure (PIP) is adjusted until the minimum pressure
that maintains adequate ventilation and oxygenation is
obtained. For normal chests, a PIP of 8–10 cmH2O in
dogs and slightly less in cats will adequately ventilate
most animals in normal body condition. Higher pres-
sures may be required in obese animals and animals
with barrel chests. 
The majority of these animals will have normal lungs
at  least  initially,  so  only  conservative  PEEP  may  be
required (up to 3 cmH2O). This will help prevent the
development and progression of atelectasis, especially if
a high FiO2 is used.  PEEP must be used with extreme
care in animals with increased ICP. 
Mechanical ventilation of animals with lung 
pathology in the absence of intracranial disease
Smaller tidal volumes (5–6 ml/kg) and higher respiratory
rates are recommended in animals with diseased lungs to
prevent  overdistension  of  normal  lung  tissue.  Over-
distension of normal lungs occurs as gas delivered during
the  inspiratory  phase  follows  the  pathway  of  least
resistance and distributes to areas of lung that are more
compliant  (i.e.  normal  lung  tissue  is  preferentially
ventilated compared with less compliant diseased tissue).
Overdistension of normal lung contributes to ventilator-
induced lung injury (VILI) and triggers a cascade of
worsening pulmonary function and the development
of multiple organ failure. Unfortunately, this type of
ventilation strategy is unable to maintain normal CO2.
However, in animals with normal intracranial compli-
ance the increases in PaO2are generally tolerated.  
PEEP is particularly useful in animals with reduced
lung compliance, as there is a tendency for lungs to
collapse during expiration. In these conditions, PEEP
prevents alveolar collapse and atelectasis. By preventing
alveolar collapse, PEEP prevents the cyclic collapse and
re-opening of alveoli that contribute to VILI. By mini-
mizing atelectasis, PEEP also reduces physiological dead
space and improves pulmonary gas exchange. 
Adverse effects of PEEP includes interference with
normal venous return during the expiratory phase of ven-
tilation. To minimize this effect, the amount of PEEP
Settings are a compromise between
pre-existing lung condition and
need to maintain normocapnia and
prevent increased ICP
Use the minimal PIP required to
achieve normoxia and normocapnia,
but limit adverse effects on venous
drainage and ICP
Avoid/use carefully in animals with
intracranial hypertensionapplied is adjusted to optimize arterial oxygenation while
maintaining normal cardiac output (and oxygen deliv-
ery). Clinically, where measurement of cardiac output is
not available, the effect of IPPV on arterial BP and
central venous pressure (CVP) can be used to assess the
impact on cardiovascular function. 
Mechanical ventilation of animals with lung 
pathology in the presence of intracranial disease 
Ventilation of animals with both lung and intracranial
disease  presents  a  unique  challenge,  as  many  of  the
ventilator strategies designed to minimize VILI have a
detrimental effect on ICP. 
The low tidal volume ventilation strategies recom-
mended in animals with lung pathology cause permissive
hypercapnia and are harmful in animals with intracranial
disease,  as  a  marked  increase  in  ICP  accompanies
increasing PaCO2. Increasing mean airway pressure also
has the potential to increase ICP due to detrimental
effects  on  venous  return  increasing  cerebral  blood
volume. The level of PIP required to ventilate these
animals adequately may be reduced by use of non-depo-
larizing neuromuscular blockers, which increase compli-
ance of the chest wall. Venous return is optimized by
increasing expiratory time and, thus, the time for blood
to return to the heart. PEEP should be avoided or used
extremely carefully in animals with intracranial disease.
(For details of neuromuscular blockers see Chapter 29.)
Increases  in  ICP  negate  any  improvement  in
oxygenation  by  reducing  cerebral  perfusion  pressure
(CPP). Furthermore, increased ICP increases the risk
of herniation and death. The use of ICP monitoring
may be worthwhile in animals with concurrent intra-
cranial disease and lung disease warranting mechanical
ventilation to ensure ventilation strategies donot exacer-
bate  intracranial  hypertension.  (For  more  details  on 
ventilation in ARDS see Further reading.) 
Ventilation of animals with pulmonary disease and
concurrent CNS disease requires intensive monitoring
of pulmonary, cardiovascular and neurological functions.
This is limited to referral hospitals. 
CARE OF THE VENTILATED ANIMAL
Appropriate  monitoring  and  supportive  care  of  the
ventilated patient are required to minimize adverse effects
of chronic intubation, ventilation and recumbency. This
section discusses some important aspects of this care.
Table 9 gives a  summary of the general nursing require-
ments of these animals. 
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Table 9 General nursing of the ventilated patient
PROCEDURE RATIONALE
Lubricate eyes Paralysed animals are unable to close eyelids and are predisposed to corneal
ulcers if eyes are allowed to dry out
Moisten and reposition tongue every 1–2 hours Prevents desiccation, circulatory stasis and swelling.Wrapping the tongue in a 
swab soaked with water can be useful for preventing desiccation
Reposition endotracheal tube every 2 hours Prevents local tracheal necrosis at site of inflated cuff. Do not inflate the cuff of
the ETT excessively.The cuff should be inflated until there is no audible leak
during inspiration. High-volume low-pressure cuffs are preferred.Ties used to
secure the ETT in place should also be repositioned every 2–4 hours to prevent
circulatory stasis of muzzle
Swab pharynx and suction stomach/ Helps minimize regurgitation and aspiration. Even when the cuff of  the ETT is 
oesophagus every 2 hours inflated, fluid can accumulate proximal to the cuff and enter the airway when
the cuff is deflated. It is important that animals with intracranial disease are
adequately sedated or anaesthetized during this procedure, as coughing will
cause a  marked increased in ICP
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Table 9 General nursing of the ventilated patient (continued)
PROCEDURE RATIONALE
Positioning  Maintain in sternal recumbency if possible, as this optimizes pulmonary and
cardiovascular functions. If positioned in lateral recumbency, turning every 2
hours may help prevent atelectasis and compression of dependent muscle groups
Head elevation In animals with intracranial disease the head should be supported so that it is
level with or slightly above the heart in order to encourage venous drainage.
Excessive elevation of the head will impair perfusion. Care must be taken to avoid
jugular venous occlusion
Environmental temperature control Monitor body temperature and warm as needed using circulating warm air,
blankets, heating pads or hot water bottles. Care must be taken to avoid
discomfort or burns from the heat source
Clean and dry Incontinence pads can be used, but must be changed regularly; alternatively,
place an indwelling urinary catheter
Sedation/analgesia
Most animals with respiratory disease will require anaes-
thesia to allow endotracheal intubation and ventilation.
Some  degree  of  sedation  or  anaesthesia  will  also  be
required in animals with neuromuscular disease, particu-
larly during recovery when animals will attempt to move,
but are still too weak to maintain their own spontaneous
ventilation or protect their upper airway. If anaesthesia is
not required to maintain immobility (e.g. animal paral-
ysed by snake envenomation), it is important to remem-
ber  that  these  animals  are  conscious  and  aware  of
environmental stimuli, including noise and touch. Some
form of analgesia/sedation is recommended to minimize
the  stress  associated  with  handling.  Agents  used  to
sedate/anaesthetize  animals  requiring  ventilation  are
discussed in Chapter 29.
Monitoring
As mechanical ventilation may have detrimental effects
on a variety of organ systems, close monitoring of venti-
lated animals is essential. 
Cardiovascular function
To ensure adequate circulating blood volume and BP and
to minimize the detrimental effects of ventilation on car-
diovascular function, measurement of arterial BP and
CVP should be performed in ventilated animals. These
techniques are described in detail in Monitoring the
cardiovascular system, p. 56. 
Pulmonary function
Adequacy of ventilation
Assessment of the adequacy of ventilation can be made by
measurement of airway pressure, capnography (see p. 50)
and measurement of arterial CO2.
Measurement of airway pressure is essential whenever
mechanical ventilation is performed, as sudden changes
in pressure can have dramatic consequences. Failure to
achieve a predetermined airway pressure indicates inad-
equate delivery of volume to the patient and may be due
to insufficient gas supply, leaks in the breathing system or
disconnection.  Abrupt  increases  in  airway  pressure
suggest sudden changes in compliance or resistance and
can be caused by obstruction or kinking of tubing, acute
bronchoconstriction or development of pneumothorax.
Gradual increases in airway pressure suggest deteriora-
tion in pulmonary function, with associated decreases in
compliance and increases in resistance. Adequacy of oxygenation
The amount of oxygen within the blood can be assessed
by measuring oxyhaemoglobin saturation (SpO2) with a
pulse oximeter (34) and measuring the partial pressure of
oxygen in arterial blood (PaO2). Calculation of oxygen
delivery to the tissues requires measurement of both
arterial oxygen content and cardiac output. Measure-
ment of mixed venous oxygen can provide an indirect
measure of adequacy of oxygen supply to the tissues.
Details of these techniques are described below. 
Neurological function 
Neurological function is influenced by the adequacy of
oxygenation, ventilation and perfusion, and a reduction
in these variables can lead to neurological deterioration.
Deterioration of neurological status will be observed
clinically by progressive mental depression in conscious
animals, dilation of pupils with absence of a PLR and
development  of  cardiorespiratory  abnormalities  (e.g.
cardiac arrhythmias, Cushing reflex [reflex bradycardia],
abnormal  breathing  patterns).  ICP  monitoring  may 
also be useful in animals with concurrent intracranial 
and pulmonary disease, particularly in those requiring
ventilation. 
Renal function 
Measurement  of  urine  output  (see  p.  60)  and  urine 
specific gravity (SG) should be performed regularly in
chronically ventilated animals to monitor the effects of
ventilation on renal function and to assess fluid balance.
Ideally, this should be performed via a sterile indwelling
urinary  catheter  and  closed  collection  system  (35). 
Measurement of blood urea, creatinine and electrolytes
should also be performed daily to monitor for changes in
renal function. 
Fluid therapy (for more details see Chapter 31)
Once volume deficits have been corrected, crystalloid
fluids  are  required  to  maintain  adequate  hydration.
As large amounts of water can be lost through evapora-
tion from the airways of ventilated animals, particularly
when non-rebreathing systems are used, it is generally
recommended that fluid administration is supplied at
1.5–2    maintenance  to  prevent  dehydration  and
maintain  adequate  hydration  of  the  airway  mucosa.
Humidification of ventilator gases will offset this effect.
In ventilated animals with intracranial disease, fluid
therapy  should  ideally  be  monitored  using  CVP  to
prevent excessive fluid administration and increases in
hydrostatic pressure.
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  35 A closed urinary collection system allows continuous
monitoring of urine output in critical patients.
  34 Multivariable monitoring recording haemoglobin
saturation and plethysmograph using pulse oximetry. 
The level of CO2 expired over time is measured using
capnography (blue wave form). Arrow = end-tidal CO2.Humidification of the airway
Ventilation  with  dry  gases  causes  drying  of  airway
secretions, decreased mucociliary clearance and asso-
ciated increased risk of secondary infection. Water lost
from  the  airway  will  increase  fluid  requirements.
Adequate  intravenous  fluid  therapy  is  essential  for
maintaining airway hydration, but heat and moisture
exchange  (HME)  devices  (see  Chapter  29)  placed
between the animal and the breathing circuit can reduce
water loss by up to 80%. These devices need to be
replaced every 6 hours to ensure optimal efficiency.  
Ideally, humidified gases should be used if ventilation
is expected to be prolonged. Even a couple of hours of
ventilation with dry gases can cause significant damage to
the upper airways and lungs. Humidifiers can be fitted to
most ventilators and are placed in the inspiratory limb of
the ventilator breathing system. Sterile saline can be
instilled into the airway at the level of the tracheal bifur-
cation and then removed via suctioning every 1–2 hours.
As this increases the risk of nosocomial infection, suc-
tioning is only recommended when secretions are exces-
sive.  Suctioning  generally  requires  the  patient  to  be
disconnected from the ventilator (open suctioning). This
predisposes to alveolar collapse. The performance of an
alveolar recruitment manoeuvre may be necessary to 
re-recruit  collapsed  alveoli.  Alveolar  recruitment  is
achieved by manually inflating the lung with a larger than
normal tidal volume or PIP than that being used for
ventilation, holding for a prolonged inspiratory time. 
Cardiovascular support in the ventilated patient
Vasoactive  agents  may  be  indicated  in  animals  with
hypotension  unresponsive  to  normalization  of  blood
volume  and  techniques  used  to  reduce  mean  airway
pressure during ventilation. Conservative approaches
to the correction of hypotension should be performed
first (fluid therapy and minimizing the delivery of vaso-
dilating agents such as anaesthetics) and preparations
made for the administration of vasoactive drugs if indi-
cated.  Close  monitoring  must  be  performed  before,
during and after pharmacological management of BP
abnormalities. Pharmacological manipulation of BP is
described in the sections on hypotension (p. 52) and
hypertension (p. 55).
Monitoring oxygenation and ventilation
Pulse oximetry
The factors that interfere with a reliable pulse oximeter
reading include local vasoconstriction, interference from
extraneous lighting, movement, haemoglobin abnormal-
ities and pigment. Pulse oximetry can be used to provide
a guide to oxygenation. It provides a non-invasive beat-
by-beat assessment of the amount of oxygen carried by
haemoglobin  within  the  arterial  blood.  However,  to
ensure accuracy, the pulse quality must be good and
reflected in the generation of a continuous plethysmo-
gram. 
Pulse oximetry measures the percentage of haemo-
globin (Hb) molecules that are saturated with oxygen and
the pulse rate. Due to the shape of the oxyhaemoglobin
dissociation  curve  (see  24),  a  saturation  of  >95%  is
required to ensure a PaO2 of >80 mmHg (10.7 kPa).
There are many physiological and technical factors that
can interfere with the pulse oximeter, so the readings
should be interpreted with a thorough understanding of
the limitations of the equipment. (Note: Pulse oximetry
does not assess the adequacy of ventiliation and severe
hypercapnia can develop despite adequate oxygen satura-
tion, especially if the patient isinspiring gases with a high
FiO2. Pulse oximetry can only be relied on to measure
oxyhaemoglobin saturation and pulse rate.) 
Capnography 
Capnography provides a breath-by-breath assessment of
the adequacy of ventilation, assuming normal cardiovas-
cular function. This technique measures CO2 in the
expired patient gases (P’ETCO2) (see 34), which approx-
imates the CO2 tension in the alveoli (PACO2). As alve-
olar gases should be in equilibrium with arterial blood,
P’ETCO2can be used to approximate PaCO2. 
Intermittent analysis of arterial blood gas samples
should  also  be  performed  to  ensure  capnography  is
providing a reliable indication of ventilation, as dis-
crepancies between arterial and end-tidal CO2can occur.
Differences between PaCO2 and P’ETCO2 are caused
by  reduced  pulmonary  blood  flow  (and  increased 
physiological dead space) due to pulmonary thrombo-
embolism, air embolism and reduced cardiac output
(heart failure, hypovolaemia). In small animal patients
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P’ETCO2 by 10–20 mmHg or more due to development
of physiological dead space. Discrepancies will also occur
due to increased dead-space ventilation, as less of the
inspired tidal volume actually reaches the alveoli. An
example of this is panting in a spontaneously breathing
animal. 
As capnography provides breath-by-breath informa-
tion and is a non-invasive monitor, it is an important tool
for assessing pulmonary and circulatory emergencies in
the ventilated patient (36). 
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Arterial blood gases
Measurement of PaO2is the gold standard for determin-
ing the amount of oxygen within arterial blood and
should be performed whenever the accuracy of pulse
oximetry is in doubt. Measurement of mixed venous
oxygen tension (blood collected from the right atrium via
a central venous catheter) can provide an indication of
the relationship between oxygen supply and demand.
An increase in the difference between arterial and mixed
venous oxygen tension suggests either decreased tissue
perfusion or increased tissue consumption. 
Calculation of oxygen delivery
Oxygen delivery to tissues is a product of cardiac output
and arterial oxygen content (DO2 = CO   CaO2). A cal-
culation of DO2 is the ultimate measure of adequacy
of tissue oxygenation, but is not always practical. CaO2
is easily calculated, as it is the sum of oxygen bound
to haemoglobin and oxygen dissolved in the plasma
(CaO2 = [SpO2   Hb   1.34] + [0.003   PaO2]). Because
of the requirement for specialist equipment, assessment
of cardiac output is usually limited to referral institutions.
As a result, cardiac output is usually extrapolated from
the measurement of BP (mean arterial pressure [MAP] =
cardiac output   systemic vascular resistance [SVR]). An
inability to obtain direct measurement of cardiac output
prevents the calculation of DO2in a clinical setting.  
CIRCULATION: CARDIOVASCULAR SUPPORT OF
THE NEUROLOGICAL PATIENT
Abnormalities of cardiovascular function can cause sec-
ondary neurological damage in animals with intracranial
disease. Hypotension leads to reduced CPP, particularly
in the presence of increased ICP (CPP = MAP   ICP).
Hypertension has the potential to increase ICP in the
presence  of  intracranial  disease.  This  occurs  when
increases in MAP are in excess of normal autoregulation
or when autoregulation is impaired. When autoregula-
tion is impaired, any increase in MAP can cause linear
increases in cerebral blood volume and ICP. Therefore,
cardiovascular function needs to be monitored closely in
neurological patients and hypotension and hypertension
managed as required.
  36 A humidifying and moisture exchange (HME)
device, placed between the patient and the anaesthetic
circuit, prevents excessive heat and fluid loss during
anaesthesia. A capnograph attached to the HME provides
breath-by-breath assessment of adequacy of ventilation.Circulatory shock/hypotension
Definition
Circulatory shock causes a significant reduction in organ
perfusion. During the compensatory phase, BP is main-
tained  by  the  responses  to  reduced  tissue  perfusion,
including increases in heart rate (37, 38), peripheral vaso-
constriction, shifts in fluid from the interstitial space to
the intravascular space and reduced urine production.
Once the fluid deficit exceeds the ability of the body to
compensate (decompensatory shock), decreases in BP
occur (39). 
In humans with head trauma, hypotension is defined
as systolic arterial blood pressure (SAP)  90 mmHg.
Similar limits of MAP in the trauma patient have not
been established in small animals, although maintenance
of CPP (MAP   ICP) at between 60 and 70 mmHg and
MAP >70 mmHg is associated with a better outcome in
head-trauma cases. In the absence of ICP monitoring it is
recommended that the MAP should be 70–80 mmHg
and the SAP should be 100 mmHg to maintain CPP in
the presence of increased ICP. Further increases in CPP
above 70 mmHg are not recommended, as the use of
aggressive fluid therapy and vasopressors to maintain
CPP above 70 mmHg is associated with systemic com-
plications such as ARDS.  
Clinical signs of circulatory shock
Instigation of appropriate therapy is dependent on early
recognition of shock. This requires a good understand-
ing of the clinical signs of circulatory shock. The clinical
signs of shock will vary depending on the severity, the
degree of compensation and the cause. 
Reduction  in  cardiac  output  causes  sympathetic
nervous stimulation, leading to tachycardia and peri-
pheral vasoconstriction (pale mucosal membranes, cold
extremities, reduced rectal temperature). If these changes
can compensate for the reduction in cardiac output, BP
will be normal. Once these compensatory responses are
overwhelmed, BP will decrease. It is essential that therapy
is started before decompensation and decreases in BP
occur in order to minimize organ damage. 
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  39 Electrocardiogram showing tachyarrhythmia, 
here associated with poor cardiac output and hypotension.
In this case urgent management is required, including
rapid correction of the cause of the arrhythmia.
  38 When loss of blood volume is severe or prolonged,
compensatory mechanisms fail and hypotension occurs, as
can be seen in this recording.
  37 Recording from a patient taken before blood loss.
Heart rate (seen here to be 106 beats per minute) and
blood pressure (wave marked with arrow), measured using
an arterial catheter, are within normal ranges.Management of circulatory shock 
Appropriate treatment depends on the cause. Arterial BP
is  influenced  by  cardiac  output  and  total  peripheral
resistance. A decrease in either cardiac oputput or total
peripheral resistance will decrease BP. Cardiac output is
the product of heart rate and stroke volume. Stroke
volume  is  determined  by  preload  (blood  volume),
myocardial contractility and afterload.  
Hypovolaemic shock 
A reduction in  circulating blood volume results in a
decreased  amount  of  blood  returning  to  the  heart
(preload), with a resultant decrease in stroke volume and
cardiac output and, therefore, BP. The most common
cause of hypovolaemic shock in the neurological patient
is haemorrhage associated with trauma or surgical losses.
Trauma  may  also  cause  hypovolaemia  due  to  loss  of
protein-rich fluid into damaged tissues such as muscle
bruises and large wounds. In immobile animals unable to
access water, dehydration may lead to hypovolaemia
once the fluid deficit exceeds 10% of body weight. 
Fluid therapy forms the cornerstone of the manage-
ment of hypovolaemia. (For details on fluid therapy see
Chapter 31.)
Vasodilatory/distributive shock
Vasodilatory  shock  is  caused  by  marked  peripheral
vasodilation, which results in relative hypovolaemia as
the vascular volume increases relative to the volume
of blood  within  the  circulation.  A  primary  cause  of
peripheral vasodilation and hypotension in animals with
neurological disease is spinal disease that interferes with
the sympathetic innervation of the splanchnic vascula-
ture. A secondary cause is the use of anaesthetic agents
that cause peripheral vasodilation (e.g. propofol, iso-
flurane,  sevoflurane).  Vasodilation  associated  with
administration of these agents is dependent on the dose
and rate of administration. The higher the dose or the
faster the rate of administration, the greater the amount
of vasodilation and the lower the BP. Vasodilation and
hypotension will also occur in any animal that develops
concurrent systemic inflammatory response syndrome
(SIRS). SIRS may develop in the presence of any factor
that can stimulate a widespread inflammatory response
(e.g. multiple organ trauma, hypoxaemia and ventilator-
induced lung injury). 
In most cases, management requires treatment of the
underlying cause. Symptomatic treatment includes fluid
therapy and administration of vasoconstrictive agents.
Drugs used to increase BP in human patients with head
trauma include noradrenalin (norepinephrine) infusion,
dopamine and phenylephrine. Vasopressin has also been
used to increase BP in critically ill animals with SIRS.
The dose rates of those agents that have been used in
small animals are: noradrenalin (norepinephrine) (0.05–2
µg/kg/minute); dopamine (5–10 µg/kg/minute); vaso-
pressin (0.5–2 IU/kg/minute) and phenylephrine (1–3
µg/kg/minute) (see Further reading). 
When sedative and anaesthetic agents are responsible
for the hypotension, the dose of the administered agent
should be reduced and fluid therapy given to animals that
do not respond to the reduction in anaesthesia.  
Cardiogenic shock
Cardiogenic shock may occur due to marked changes in
heart rate and rhythm, and reduced myocardial contrac-
tility. Abnormalities in cardiac rhythm include those
associated with fast heart rates (tachyarrhythmias) and
slow heart rates (bradyarrhythmias). Hypotension occurs
secondary to fast heart rates, as there is decreased time
for the heart to fill during diastole, resulting in reduced
stroke volume and cardiac output. In addition, the high
heart rate increases myocardial oxygen demand when
oxygen delivery may be compromised. This predisposes
to myocardial ischaemia, which may further exacerbate
the arrhythmia. Slow heart rates cause hypotension, as
cardiac output is dependent on heart rate (CO = SV  
HR).  Poor  myocardial  contractility  decreases  the
amount of blood able to be pumped by the heart and,
therefore, cardiac output.
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Tachyarrhythmias
Causes of tachyarrhythmias associated with neurological
disease include brainstem disease/compression. Myo-
cardial degeneration and necrosis are also reported to
occur following cranial and spinal trauma in dogs. Causes
associated  with  other  systemic  abnormalities  include
myocardial contusions secondary to thoracic trauma and
myocardial  ischaemia  secondary  to  hypovolaemia
(e.g. haemorrhage  from  trauma  or  surgery).  Fluid,
electrolyte and acid–base abnormalities may also occur
secondary to inappetence, an inability to eat and drink or
losses from the gastrointestinal tract or kidneys. (For
more details on fluid and electrolyte abnormalities that
occur commonly in neurological disease see Chapters 3
and 31.) Persistent tachycardia can also lead to myo-
cardial ischaemia and arrhythmias, as the increase in
heart rate causes both an increase in myocardial oxygen
consumption and a reduction in oxygen delivery due to
decreased time for the heart muscle to be perfused.
Management of arrhythmias involves the correction
of all possible underlying causes. Brainstem compression
and/or  herniation  requires  specific  treatment  for
increased ICP (see Chapter 20). Brainstem ischaemia can
occur due to either increased ICP or decreased BP. Any
concurrent electrolyte and acid–base abnormalities also
need to be corrected. Any cause of persistent tachycardia,
including pain, hypovolaemia or hypotension, needs to
be corrected to minimize the risk of exacerbating or con-
tributing to the development of tachyarrhythmias. 
Specific anti-arrhythmic medication is indicated if the
arrhythmia  persists  despite  treatment  of  all  possible
causes and/or if tissue perfusion is compromised. Specif-
ic  anti-arrhythmics  for  ventricular  tachyarrhythmias
include lidocaine (sodium channel blocker) and beta
blockers (e.g. esmolol). Supraventricular tachyarrhyth-
mias can be treated using beta blockers. (For dose rates
commonly used in clinical cases see Further reading.) 
Bradyarrhythmias 
The main cause of bradycardia and bradyarrhythmias in
animals with neurological disease is brainstem compres-
sion (Cushing reflex). Brainstem compression causes
sympathetic  stimulation,  which  results  in  a  marked
increase in peripheral arterial BP. Initially, the heart rate
also increases; however, the marked hypertension ulti-
mately  causes  a  reflex  decrease  in  heart  rate  due  to
baroreceptor stimulation. Bradycardia may also occur
secondary to drug overdose (e.g. opioid administration).
Severe  hypothermia  and  electrolyte  abnormalities
(hyperkalaemia and hypokalaemia) may also contribute
to bradycardia in any critically ill patient.
Brainstem compression requires specific treatment to
reduce ICP (diuretics, hyperventilation). (For details on
specific management of increased ICP see Chapter 20.)
Bradycardia secondary to opioid overdose requires a
reduced dose of opioids +/- administration of reversal
agents such as naloxone. Specific treatment of bradycar-
dia requires administration of anticholinergics such as
atropine. As these agents can mask the signs of brainstem
herniation (e.g. pupil and heart rate changes), use of these
agents in animals with intracranial disease needs to be
performed carefully and increased ICP as a cause of the
bradycardia needs to be ruled out before these agents are
administered.  
Poor myocardial contractility
Decreased cardiac muscle contraction most commonly
occurs in neurological patients secondary to the use of
anaesthetic and sedative drugs. Development of SIRS
secondary to prolonged hypotension, hypoxaemia, ven-
tilator-induced injury or multiple organ trauma may be
another cause of reduced myocardial contractility in the
neurological patient.
Improving  myocardial  contractility  requires  the
identification and treatment of underlying causes. For
drug-induced decreases in contractility, delivery of the
agent needs to be decreased or stopped if possible. Use of
multimodal anaesthesia with opioid-based protocols will
reduce the requirement for the more cardiovascular and
respiratory depressant anaesthetic drugs. The undesir-
able effects of anaesthesia can also be minimized by using
short-acting agents that can be titrated to effect. (For
more details of methods of reducing anaesthetic-related
cardiovascular depression see Chapter 29.)   
Inotropes are indicated when management of the
underlying cause does not improve myocardial contrac-
tility  or  when  urgent  improvement  in  perfusion  is
required. Inotropes that can be used include dopamine
(2–5 µg/kg/min) or dobutamine (2–5 µg/kg/min). 
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Obstructive shock occurs due to physical interference
with venous return to the heart resulting in decreased
preload  and,  therefore,  stroke  volume  and  cardiac
output. In animals with trauma, obstruction to venous
return may occur in association with pneumothorax. In
these cases, prompt removal of the air by thoracocentesis
or a chest drain will result in resolution of the shock. 
Hypertension
Definition 
In non-neurological patients, hypertension is defined as
an MAP of >100 mmHg and a SAP of >150 mmHg. In
neurological patients, increases in mean BP and, there-
fore, CPP outside the normal autoregulatory range of
the brain cause linear increases in blood volume and ICP
(40). In addition, abnormal brain tissue loses the ability to
autoregulate. In these regions, any increase in mean BP is
associated with an increase in cerebral blood volume and,
potentially, an increase in ICP. Maintenance of a stable
normal BP is therefore important in these animals to
prevent increases in ICP. 
Causes of hypertension
As described above, MAP =CO  SVR. Cardiac output is
dependent on heart rate and stroke volume, which in
turn are dependent on preload, contractility and after-
load. Therefore, an increase in any of these factors may
increase BP. The extent of the increase will depend on
the degree of compensation.
Causes  of  hypertension  in  neurological  patients
include  peripheral  vasoconstriction,  tachycardia  and
hypervolaemia (increased preload). Peripheral vasocon-
striction can occur due to increased ICP and brainstem
compression (Cushing reflex) in animals with intracranial
disease.  Peripheral  vasoconstriction,  tachycardia  and
associated  hypertension  may  also  occur  secondary  to
sympathetic stimulation caused by pain and anxiety.
Management  
Specific management of increased ICP is detailed in
Chapter 20. To minimize other causes of hypertension,
adequate pain management and careful administration of
fluids  are  important.  Where  hypertension  persists
despite correction of underlying causes, specific pharma-
cological treatment may be required to prevent detri-
mental effects on ICP and neurological function. 
Persistent hypertension, despite adequate analgesia,
can be treated by the administration of beta receptor
antagonists or calcium channel blockers. Agents that
have been used in human patients with head trauma
include esmolol (  blocker), labetalol (mixed   and  
blocker) and nicardipine (calcium channel blocker). Use
of these agents in small animal neurological patients has
not been reported. Esmolol is commonly used to treat
tachyarrhythmias in small animals and labetolol has been
described for use in a hypertensive crisis. Nicardipine is
not used clinically in small animals at present; however,
amlodipine, a calcium channel blocker used in small
animals with cardiovascular disease, may be a suitable
alternative. The dose rates of these agents can be found
in critical care texts (see Further reading). 
Sodium nitroprusside is also used in small animal
patients with cardiac disease to control hypertension;
however,  this  agent  is  best  avoided  in  patients  with
neurological injury due to its risk of causing increases
inICP. 
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  40 Relationship between cerebral blood flow and
intracranial pressure in response to changes in cerebral
perfusion pressure, arterial carbon dioxide and oxygen
tension. Normal pressure autoregulation of blood flow
(dotted red line) maintains appropriate cerebral blood
flow despite fluctuation in the mean arterial pressure.
Increased PaCO2 (green line) causes a global increase in
cerebral blood flow that exceeds demand. Cerebral blood
flow is unchanged until PaO2 levels fall below approxi-
mately 60 mmHg, when it rises sharply. 
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The use of any agent that decreases BP should be
associated with close monitoring of BP to ensure exces-
sive reduction and hypotension do  not occur. 
Monitoring the cardiovascular system
Arterial blood pressure
Arterial BP can be measured non-invasively using oscil-
lometric or Doppler techniques (41). Oscillometric tech-
niques (e.g. device for indirect non-invasive, automated,
mean arterial pressure [DINAMAP]) provide automatic
intermittent measurement of mean, systolic and diastolic
pressure and pulse rate. The minimum amount of time
between repeated measurements is 2 minutes. Many of
the commercial systems available are unreliable in very
small  animals,  such  as  cats,  and  in  hypotensive  or
bradycardic patients. However, the accuracy in these sit-
uations  is  improving  with  newer equipment  that  is
becoming more readily available. The Doppler tech-
nique is performed manually and is limited to measure-
ment of SAP. However, this technique is more reliable in
small animals and in shocked patients. 
In unstable animals or chronically ventilated animals,
invasive BP monitoring via an arterial catheter (42) is
preferred  over  non-invasive  methods.  Invasive  tech-
niques allow continuous monitoring of BP. Catheters are
most commonly inserted in the dorsal pedal artery in
small animals. In addition, arterial blood gases can be
obtained  via  the  arterial  catheter,  allowing  accurate
assessment of pulmonary function and oxygen delivery. 
  42 Arterial blood pressure is commonly measured
directly via a catheter placed in the dorsal pedal artery. 
(a) Prior to placement, the hair over the medial surface of
the dorsal tarsus is clipped and the site disinfected. 
(b) A small amount of lidocaine (2%) can be injected sub-
cutaneously over the artery at the intended site of catheter
insertion. This is particularly useful in conscious animals
to prevent discomfort and movement during insertion. 
It can also be useful in anaesthetized animals as the vaso-
dilation associated with the lidocaine administration can
aid catheter placement. (c) Prior to catheter placement, a
small stab incision can be made in the skin. This allows
the catheter to be inserted with greater control as there is
no longer any skin resistance. The artery is then gently
palpated at the site of insertion and the catheter inserted
gently but firmly in the direction of palpation. If the artery
continues to be palpable as the catheter is inserted, then it
is likely that the catheter is too far lateral or medial to the
artery. If the artery cannot be palpated, the catheter may
be between the artery and skin. A flash of blood will enter
the hub of the stylet once the arterial wall has been
penetrated by the bevel of the stylet. It is essential that the
catheter is not separated from the stylet until at least
5m m   h a v e   b e e n   i n s e r t e d   t o   e n s u r e   t h a t   b o t h   s t y l e t   a n d
catheter have penetrated the wall of the artery. If this has
not occurred, the catheter will not be able to be inserted.
(d) Taping and/or superglue can be used to secure the
catheter in place. (e) The catheter can then be connected
to the fluid line to allow blood-pressure monitoring.
  41 The Doppler technique can be very useful for
measuring blood pressure, particularly in small animals.RESPIRATORY AND CARDIOVASCULAR SUPPORT 57
e
a b
c da
ADMISSION AND NEURODIAGNOSTIC TESTS 58
c
b
d
f
h
e
gRESPIRATORY AND CARDIOVASCULAR SUPPORT 59
Central venous pressure
CVP is measured using a fluid-filled catheter inserted
into  the  cranial  vena  cava  via  the  jugular  vein  (43).
Placement  of  the  catheter  in  the  jugular  vein  may
increase the risk of disturbance to venous return and
increased ICP. An alternative is to place a percutaneous
central catheter, which is passed into the caudal vena cava
via a catheter in the medial saphenous vein (44). Where
this is not possible, a jugular venous catheter can be
placed, taking care not to occlude the jugular during
placement  (surgical  exposure  may  be  required)  and 
utilizing a catheter with as small a diameter as possible to 
minimize interference with venous return. The use of
neck bandages over these catheters is discouraged in
animals with intracranial disease. 
CVP in spontaneously breathing animals is normally
between 0 and 10 cm H2O. CVP is determined by the
amount of blood returning to the heart and the ability of
the heart to pump this blood. Therefore, measurement
of CVP will help differentiate cardiac and hypovolaemic
causes of hypotension and determine appropriate treat-
ment. A low BP accompanied by a high CVP suggests
that  the  heart  is  unable  effectively  to  pump  blood
returning to the heart, while low BP and CVP supports a
reduction in the volume of blood returning to the heart
(i.e. hypovolaemia). In contrast, a high CVP and high
MAP would suggest hypervolaemia.  
Measurement of CVP is helpful to determine the
extent of adverse effects of ventilation. A high CVP can
be caused by high mean intrathoracic pressure used for
ventilation. In such a case, the PIP and/or PEEP requires
adjustment. 
  43 Insertion of a catheter into the jugular vein. 
Prior to placement, the dead space of the catheter is
filled with saline or heparinized saline and an area
over the selected jugular vein is clipped. The site is then
disinfected. A roll of bandage or gauze placed under the
neck can be useful for increasing visibility of the vein,
but care should be taken not to occlude the dependent
jugular vein in animals with intracranial disease. 
(a) A small stab incision can be made (carefully) in the
skin over the jugular vein, as shown by tenting the skin
between two fingers; this assists placement of the
catheter. (b) With an assistant compressing the vein
proximally, the introducer (a needle or catheter) is
inserted through the stab incision into the jugular vein.
(c) Once the guide wire has been placed, the needle
introducer is removed, leaving the wire in place. 
(d) The dilator is then passed over the wire and
threaded into the vein. (e) A gentle but firm twisting
action will help insert the dilator through the skin and
vessel wall. The dilator is them removed, again leaving
the wire in place. At this stage some haemorrhage will
occur at the entry site as the hole in the vessel wall is
larger than the wire. Gentle pressure at the entry site
using a sterile swab will reduce the amount of
haemorrhage until the catheter is placed. (f) The
catheter is then passed over the guide wire. During
insertion of the catheter it is essential to maintain a hold
on the guide wire at all times. The wire is inserted into
the proximal end of the catheter and gradually passed up
the catheter. (g) When the hub of the catheter is
reached, the injection port is removed and the wire
passed through the end of the catheter. Once the wire
passes through the hub, the operator can hold the wire
and pass the catheter over the wire into the vein.
The wire is then removed and the injection port
replaced. The catheter is flushed with saline. (h) The
catheter is sutured in place. A sterile dressing is placed
over the entry wound. Neck bandages should not be
used in animals with intracranial disease, but can be
used in other patients to help secure the catheter in
place.
  44 Central venous pressure can be measured via a
catheter placed in the caudal vena cava via the medial
saphenous vein.Urine output
Urine output provides an indirect indication of renal
perfusion and therefore circulating blood volume and
hydration status. It is an extremely valuable tool for
assessing  the  adequacy  of  cardiovascular  function  in
neurological patients. 
Urine  output  is  normally  1–2  ml/kg/hour  in
normovolaemic patients on normal maintenance fluid
rates.  Higher  rates  should  be  expected  in  normally
hydrated animals receiving more than maintenance rates
of fluid. Higher than normal output is also expected in
animals that have received diuretics or glucocorticoids.
(For more details on interpretation of changes in urine
output see Chapter 31.) 
Monitoring of urine output is easy, cheap and inform-
ative. An indwelling urinary catheter is inserted and a
closed collection system set up. It is an extremely useful
way of assessing fluid balance in unstable neurological
patients, particularly those receiving diuretics, where
fluid  losses  in  the  urine  are  higher  than  normal.  In
addition, animals with traumatic brain injury may have
alterations in the reabsorption of renal sodium and water
(e.g. central diabetes insipidus [DI] resulting in abnormal
urine production and urine SG). 
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